Our Blog Melanoma360

Featured image for “Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative ”
06/18/2025

Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative 

In 2016, the late Valerie Guild—founder and then-president of AIM at Melanoma—attended a melanoma conference and noticed something striking: While…
Blog - Melanoma360
Featured image for “Melanoma News and Highlights You Don’t Want to Miss”
06/18/2025

Melanoma News and Highlights You Don’t Want to Miss

We know staying informed about melanoma research and treatments is important to you. That’s why we’ve put together some of…
Blog - Melanoma360
Melanoma Research
Featured image for “Coping with Cancer: DBT Skills for Emotional Resilience”
06/10/2025

Coping with Cancer: DBT Skills for Emotional Resilience

In this enlightening episode, we are joined by Elizabeth Cohn Stuntz, LCSW, a cancer survivor and expert in emotional well-being,…
Blog - Melanoma360
Podcast
Featured image for “May in Review: A Marathon Month of Melanoma Awareness, Education, and Community”
06/06/2025

May in Review: A Marathon Month of Melanoma Awareness, Education, and Community

By Sam Guild, President, AIM at Melanoma Foundation Wow! May truly felt like running a marathon—and crossing the finish line…
Blog - Melanoma360
President's Letter
Featured image for “AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild”
06/06/2025

AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild

On Saturday, May 31st, AIM supporters, including many influential figures in the melanoma community, gathered for AIM at Melanoma’s 4th…
Blog - Melanoma360
Philanthropy
Featured image for “Nivolumab at Micro Doses Works Better than Chemotherapy Against Relapsed Cancer”
06/05/2025

Nivolumab at Micro Doses Works Better than Chemotherapy Against Relapsed Cancer

In Mumbai, India, and other parts of the world, immunotherapy is not always available for every patient who needs it.…
Blog - Melanoma360
Melanoma Research
Featured image for “The Time of Day Pembrolizumab is Administered May Link to Patient Survival”
06/05/2025

The Time of Day Pembrolizumab is Administered May Link to Patient Survival

Timing matters. A study presented at the annual meeting of the American Society of Clinical Oncology in Chicago suggests that…
Blog - Melanoma360
Melanoma Research
Featured image for “Three New Immunotherapy Agents Tested Against Melanoma in Phase 2 Clinical Trials”
06/05/2025

Three New Immunotherapy Agents Tested Against Melanoma in Phase 2 Clinical Trials

Several new agents designed to reactivate the immune system were tested in combination with FDA-approved immunotherapies, as reported in data…
Blog - Melanoma360
Melanoma Research
Featured image for “Genetic Test a Potential Alternative to Sentinel Lymph Node Biopsy”
06/05/2025

Genetic Test a Potential Alternative to Sentinel Lymph Node Biopsy

There may be a non-invasive option available for patients with head and neck melanoma who cannot easily receive a sentinel…
Blog - Melanoma360
Melanoma Research
Featured image for “New Therapy in Clinical Trial Returns Immunotherapeutic Activity to Resistant Melanoma”
06/05/2025

New Therapy in Clinical Trial Returns Immunotherapeutic Activity to Resistant Melanoma

A group in Italy may have found a way to revive the response to immunotherapy in patients who have developed…
Blog - Melanoma360
Melanoma Research
06/18/2025

Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative 

In 2016, the late Valerie Guild—founder and then-president of AIM at Melanoma—attended a melanoma conference and noticed something striking: While…
Featured image for “Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative ”
Blog - Melanoma360
06/18/2025

Melanoma News and Highlights You Don’t Want to Miss

We know staying informed about melanoma research and treatments is important to you. That’s why we’ve put together some of…
Featured image for “Melanoma News and Highlights You Don’t Want to Miss”
Blog - Melanoma360
 | 
Melanoma Research
06/10/2025

Coping with Cancer: DBT Skills for Emotional Resilience

In this enlightening episode, we are joined by Elizabeth Cohn Stuntz, LCSW, a cancer survivor and expert in emotional well-being,…
Featured image for “Coping with Cancer: DBT Skills for Emotional Resilience”
Blog - Melanoma360
 | 
Podcast
06/06/2025

May in Review: A Marathon Month of Melanoma Awareness, Education, and Community

By Sam Guild, President, AIM at Melanoma Foundation Wow! May truly felt like running a marathon—and crossing the finish line…
Featured image for “May in Review: A Marathon Month of Melanoma Awareness, Education, and Community”
Blog - Melanoma360
 | 
President's Letter
06/06/2025

AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild

On Saturday, May 31st, AIM supporters, including many influential figures in the melanoma community, gathered for AIM at Melanoma’s 4th…
Featured image for “AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild”
Blog - Melanoma360
 | 
Philanthropy
06/05/2025

Nivolumab at Micro Doses Works Better than Chemotherapy Against Relapsed Cancer

In Mumbai, India, and other parts of the world, immunotherapy is not always available for every patient who needs it.…
Featured image for “Nivolumab at Micro Doses Works Better than Chemotherapy Against Relapsed Cancer”
Blog - Melanoma360
 | 
Melanoma Research
06/05/2025

The Time of Day Pembrolizumab is Administered May Link to Patient Survival

Timing matters. A study presented at the annual meeting of the American Society of Clinical Oncology in Chicago suggests that…
Featured image for “The Time of Day Pembrolizumab is Administered May Link to Patient Survival”
Blog - Melanoma360
 | 
Melanoma Research
06/05/2025

Three New Immunotherapy Agents Tested Against Melanoma in Phase 2 Clinical Trials

Several new agents designed to reactivate the immune system were tested in combination with FDA-approved immunotherapies, as reported in data…
Featured image for “Three New Immunotherapy Agents Tested Against Melanoma in Phase 2 Clinical Trials”
Blog - Melanoma360
 | 
Melanoma Research
06/05/2025

Genetic Test a Potential Alternative to Sentinel Lymph Node Biopsy

There may be a non-invasive option available for patients with head and neck melanoma who cannot easily receive a sentinel…
Featured image for “Genetic Test a Potential Alternative to Sentinel Lymph Node Biopsy”
Blog - Melanoma360
 | 
Melanoma Research
06/05/2025

New Therapy in Clinical Trial Returns Immunotherapeutic Activity to Resistant Melanoma

A group in Italy may have found a way to revive the response to immunotherapy in patients who have developed…
Featured image for “New Therapy in Clinical Trial Returns Immunotherapeutic Activity to Resistant Melanoma”
Blog - Melanoma360
 | 
Melanoma Research